feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development",https://benzinga.com/general/biotech/22/02/25774701/the-daily-biotech-pulse-kodiak-sinks-on-adverse-study-outcome-marinus-flags-delay-in-clinical-tri,https://bit.ly/3BNi8of
Benzinga,Jumia Clocks 26% Revenue Growth In Q4,https://benzinga.com/news/earnings/22/02/25774588/jumia-clocks-26-revenue-growth-in-q4,https://bit.ly/3sfeIrr
